RLAY Relay Therapeutics, Inc.
$12.51
▼ 3.17%
38
Value
14
P/E-8.25
8
P/B3.50
46
P/S221.69
0
EV/EBITDA-7.68
5
Growth
66
Revenue Growth53.4%
100
EPS Growth31.8%
45
FCF Growth6.1%
45
Momentum
76
12-Month Return297.1%
100
3-Month Return53.5%
100
1-Month Return-13.8%
28
RSI (14)18.05
60
50/200 MABullish
75
Profitability
17
ROE-43.9%
43
ROA-39.0%
0
Gross Margin59.3%
52
Operating Margin-2776.6%
0
Net Margin-2554.1%
0
FCF Yield-9.0%
0
Risk
16
Beta1.75
35
60-Day Volatility72.6%
0
QScore Analysis